# TherapeuticsMD Announces Full Year 2023 Financial Results
Canonical URL: https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-full-year-2023-financial-results
Ticker: TXMD
Company: TherapeuticsMD
Source: TherapeuticsMD
Published: 2024-03-29 20:00 EST
Original Source URL: https://ir.therapeuticsmd.com
## Summary

• Evaluation of strategic alternatives continues BOCA RATON, Fla. --(BUSINESS WIRE)--Mar. 29, 2024-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31,

## Article Body
• Evaluation of strategic alternatives continues BOCA RATON, Fla. --(BUSINESS WIRE)--Mar. 29, 2024-- TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31,
## Recent Company News
- 2026-05-12 20:05 EST — [TherapeuticsMD Announces First Quarter 2026 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2026-financial-results) — Source: TherapeuticsMD
- 2026-03-30 20:05 EST — [TherapeuticsMD Announces Full Year 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-full-year-2025-financial-results) — Source: TherapeuticsMD
- 2025-11-12 21:05 EST — [TherapeuticsMD Announces Third Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-third-quarter-2025-financial-results) — Source: TherapeuticsMD
- 2025-08-12 20:05 EST — [TherapeuticsMD Announces Second Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-second-quarter-2025-financial-results) — Source: TherapeuticsMD
- 2025-05-13 20:05 EST — [TherapeuticsMD Announces First Quarter 2025 Financial Results](https://biopharmsignal.com/news/TXMD/therapeuticsmd-announces-first-quarter-2025-financial-results) — Source: TherapeuticsMD
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)